Technology
Here’s Why Pfizer and BioNTech Are Selling Their Vaccine at Cost – Motley Fool
The humanitarian move might help the companies gain additional for-profit contracts in the future.
Pfizer(NYSE:PFE) and BioNTech(NASDAQ:BNTX) recently agreed to sell their COVID-19 vaccine to the U.S. government at cost. In this video from Motley Fool Live, recorded on June 14, Fool.com contributors Brian Orelli and Keith Speights discuss why the companies…
Continue Reading
-
Noosa News20 hours agoFamily pleads for help after 17-year-old Pheobe Bishop disappears in Bundaberg before flight
-
Noosa News23 hours agoNo conviction recorded for teen behind attack on Peter Dutton’s office
-
Business21 hours agoASX 200 lifts on the RBA’s latest interest rate call
-
Business13 hours agoIs Warren Buffett’s Berkshire Hathaway the smartest investment you can make today?